Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met

Sabitha Papineni, Sudhakar Chintharlapalli, Maen Abdelrahim, Syng Ook Lee, Robert Burghardt, Ala Abudayyeh, Cheryl Baker, Luis Herrera, Stephen Safe

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

The non-steroidal anti-inflammatory drug tolfenamic acid (TA) inhibits proliferation of SEG-1 and BIC-1 esophageal cancer cells with half-maximal growth inhibitory concentration values of 36 and 48 μM, respectively. TA also increased Annexin V staining in both cell lines, indicative of proapoptotic activity. Treatment of SEG-1 and BIC-1 cells with TA for up to 72 h decreased expression of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 and this was accompanied by decreased expression of the well-characterized Sp-regulated genes cyclin D1, vascular endothelial growth factor and survivin. TA also decreased hepatocyte growth factor receptor, (c-Met), a receptor tyrosine kinase that is overexpressed in esophageal cancer cells and tumors and is an important drug target. Knockdown of Sp1, Sp3 and Sp4 by RNA interference in SEG-1 and BIC-1 cells also decreased c-Met expression, demonstrating that c-Met is an Sp-regulated gene in esophageal cancer cells. Sp1 was overexpressed in esophageal cancer cells and tumors and increased Sp1 staining was observed in esophageal tumors from patients. TA (20 mg/kg/ day) also decreased tumor growth and weight in athymic nude mice bearing SEG-1 cells as xenografts and this was accompanied by increased apoptosis and decreased Sp1 and c-Met staining in tumors from treated mice. Thus, TA-dependent downregulation of Sp transcription factors and c-Met defines a novel chemotherapeutic approach for treatment of esophageal cancer.

Original languageEnglish (US)
Pages (from-to)1193-1201
Number of pages9
JournalCarcinogenesis
Volume30
Issue number7
DOIs
StatePublished - 2009

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met'. Together they form a unique fingerprint.

Cite this